GSK143 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

GSK 143 has pharmacological activity which is used in treatment of retinoblastoma protein (Rb)-positive cancers using kinase or BCL-2 inhibitors in combination with CDK4/6 inhibitors.

GSK143 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

GSK143 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Beckham Medical Technology Co., Ltd	021-13816613772 13816613772	huahero21@sina.com	China	685	55
Shanghai Hongye Biotechnology Co. Ltd	400-9205774	sales@glpbio.cn	China	6777	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Nantong QuanYi Biotechnology Co., Ltd	0513-66337626 18051384581	sales@chemhifuture.com	China	5018	58

---

• GSK143
• 2-[[(3R,4R)-3-aminooxan-4-yl]amino]-4-(4-methylanilino)pyrimidine-5-carboxamide
• GSK143 (GSK-143
• 5-Pyrimidinecarboxamide, 2-[[(3R,4R)-3-aminotetrahydro-2H-pyran-4-yl]amino]-4-[(4-methylphenyl)amino]-
• 1240390-27-5